Associations between common contraceptive use and circulating inflammatory biomarkers
American Journal of Epidemiology · 2025
DOI: 10.1093/aje/kwae135 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Epidemiology, 2025. Verfasst von Jennifer M Mongiovi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States. Hauptthemen laut MEDLINE: C-Reactive Protein, Contraceptives, Oral, Inflammation, Intrauterine Devices. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Ovarian cancer incidence has declined in recent decades, due in part to oral contraceptive (OC) use and tubal ligation. However, intrauterine device (IUD) use has increasingly replaced OC use. As ovarian cancer is an inflammation-related disease, we examined the association of OC use, IUD use, and tubal ligation with plasma levels of C-reactive protein (CRP), interleukin 6, and soluble tumor necrosis factor α receptor 2 in the Nurses’ Health Study (NHS) and NHSII. After adjusting for reproductive, hormonal, and lifestyle factors and mutual adjustment for other methods of contraception, there were no differences in inflammatory markers between ever and never use of each method. However, CRP levels decreased from an average of 30.4% (95% CI, –53.6 to 4.4) with every 5 years since initial IUD use (P-trend = .03), while CRP increased an average of 9.9% (95% CI, 5.7, 14.3) with every 5 years of use of OC (P-trend < .0001) as well as differences by body mass index and menopausal status. Our results suggest IUD use and tubal ligation are not associated with higher circulating inflammatory markers long term, although long duration of OC use may increase generalized inflammation, which may in part explain why its protective effect wanes over time. This article is part of a Special Collection on Gynecological Cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
- Obstetrics and Gynecology Department, Brigham and Women's Hospital, Boston, MA, United States.
- Department of Medical Oncology, Dana Farber Harvard Cancer Center, Boston, MA, United States.
- Division of Adolescent and Young Adult Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States.
- Boston Center for Endometriosis, Brigham and Women's Hospital and Boston Children's Hospital, Boston, MA, United States.
- Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, United States.
ORCID-Profile: Jennifer M Mongiovi, Ana Babic, Naoko Sasamoto, Amy L Shafrir, Tianyi Huang, Mary K Townsend, Lauren C Peres, Shelley S Tworoger, Kathryn L Terry
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Mongiovi, J. M., Babic, A., Sasamoto, N., Shafrir, A. L., Huang, T., Townsend, M. K., Peres, L. C., Tworoger, S. S., & Terry, K. L. (2025). Associations between common contraceptive use and circulating inflammatory biomarkers. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwae135
Vancouver
Mongiovi JM, Babic A, Sasamoto N, Shafrir AL, Huang T, Townsend MK, et al. Associations between common contraceptive use and circulating inflammatory biomarkers. American Journal of Epidemiology. 2025. doi:10.1093/aje/kwae135
BibTeX
@article{Mongiovi2025,
author = {Mongiovi, Jennifer M and Babic, Ana and Sasamoto, Naoko and Shafrir, Amy L and Huang, Tianyi and Townsend, Mary K and Peres, Lauren C and Tworoger, Shelley S and Terry, Kathryn L},
title = {Associations between common contraceptive use and circulating inflammatory biomarkers},
journal = {American Journal of Epidemiology},
year = {2025},
doi = {10.1093/aje/kwae135}
}
EUVIMED